Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants
Clinical trial NCT06304740 · TERMINATED
Trial details
- NCT number
- NCT06304740
- Sponsor
- Inmagene LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-06
- Primary completion
- 2024-08-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.